EPISODE · Oct 2, 2024 · 9 MIN
Wednesday, October 2, 2024
from The Gist Healthcare Podcast
CVS is rumored to be weighing breaking up its retail and insurance businesses amid investor pressure. Johnson & Johnson is abandoning its controversial 340B drug discount rebate plan. And, The Biden Administration is no longer pursuing its push for greater Medicaid drug price transparency, according to a report. We’ll get that story--and more--coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
CVS is rumored to be weighing breaking up its retail and insurance businesses amid investor pressure. Johnson & Johnson is abandoning its controversial 340B drug discount rebate plan. And, The Biden Administration is no longer pursuing its push for greater Medicaid drug price transparency, according to a report. We’ll get that story--and more--coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Wednesday, October 2, 2024
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m